Takeda Pharmaceutical Company Limited
4502
株式のランク
#378
Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise... Takeda Pharmaceutical Company Limited is a global biopharmaceutical enterprise engaged in the discovery, development, manufacturing, marketing, and out-licensing of various medical products. The company's operations span Japan, the United States, Europe, Canada, Latin America, Russia, and other regions across Asia and internationally. Takeda concentrates its efforts on key therapeutic areas such as gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience. Its extensive product range includes well-known brands like Entyvio, Takhzyro, Velcade, and Vyvanse. To advance its pipeline and innovation, Takeda actively fosters numerous collaborations, in-licensing agreements, research partnerships, and strategic alliances with a diverse array of organizations, including academic institutions like the University of Texas MD Anderson Cancer Center and biotech firms such as Neurocrine Biosciences, Inc. and Arrowhead Pharmaceuticals Inc. Established in 1781, the company maintains its headquarters in Tokyo, Japan.
株価
$40.26
時価総額
$64.06B
変化（1日）
0.71%
変化（1年）
42.44%
国
JP
取引 Takeda Pharmaceutical Company Limited (4502)
カテゴリー
Healthcare
Takeda Pharmaceutical Company Limited（4502）の利益
2026 時点の利益 TTM: 0
Takeda Pharmaceutical Company Limited の最新の財務報告によると、同社の現在の利益は 0 です。2026 年には 0 の利益を上げ、これは 2026 年の利益 0 と 同等 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Takeda Pharmaceutical Company Limited の利益の推移（2026 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 提供された日付のデータは十分ではありません。 | ||
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
CH
|
|
| $1.76B | - |
IN
|
|
| - | - |
CN
|
